Clinical trial
Piloting the IPROACTIF Program to Preserve Functioning and Prevent Cognitive Decline
NCT04682977 is registered in ClinicalTrials.gov with University of Illinois at Chicago as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Piloting the IPROACTIF Program to Preserve Functioning and Prevent Cognitive Decline
- Lead sponsor
- University of Illinois at Chicago
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 11, 2021
- Completion date
- March 1, 2024
- Enrollment
- 45 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
heart disease (coronary artery disease, ischemic heart disease, hypertensive heart disease), uncontrolled diabetes (hba1c ≥ 10)